H

Huaxia Eye Hospital Group Co Ltd
SZSE:301267

Watchlist Manager
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Watchlist
Price: 20.18 CNY -0.1% Market Closed
Market Cap: 17B CNY
Have any thoughts about
Huaxia Eye Hospital Group Co Ltd?
Write Note

Huaxia Eye Hospital Group Co Ltd
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Huaxia Eye Hospital Group Co Ltd
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Depreciation & Amortization
-ÂĄ90m
CAGR 3-Years
-22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
Depreciation & Amortization
-ÂĄ69.2m
CAGR 3-Years
-50%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hengkang Medical Group Co Ltd
SZSE:002219
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
X
XiAn International Medical Investment Co Ltd
SZSE:000516
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sanbo Hospital Management Group Ltd
SZSE:301293
Depreciation & Amortization
-ÂĄ9.6m
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Huaxia Eye Hospital Group Co Ltd
Glance View

Market Cap
17B CNY
Industry
Health Care

Huaxia Eye Hospital Group Co Ltd has positioned itself as a key player in China’s healthcare landscape, specializing in comprehensive ophthalmic services. Emerging from the early stirrings of China's reforms in the healthcare sector, Huaxia capitalized on a burgeoning demand for specialized medical care. With roots tracing back to when accessible eye care was a luxury in China, Huaxia recognized the immense potential in providing quality eye treatments. As the country urbanized rapidly, vision ailments became increasingly prevalent, creating a vast market for ocular health services. Huaxia seized this opportunity by establishing a network of state-of-the-art facilities across major cities, providing services ranging from basic eye examinations to complex surgeries. The company's revenue model is built on a multifaceted approach, combining patient volume with specialized treatments. Catering to a diverse demographic, Huaxia offers tiered service options that suit various financial capacities, ensuring a steady stream of income. Beyond individual consultations, the company has fostered partnerships with corporations and insurance providers, further securing a stable client base. Moreover, Huaxia invests significantly in pioneering medical technology and staff training, enhancing its reputation and thereby drawing more patients seeking top-notch care. Through strategic expansion and consistently leveraging advancements in ophthalmology, Huaxia Eye Hospital Group Co Ltd has solidified its place not just as a healthcare provider, but as a critical architect shaping the future of eye care in China.

Intrinsic Value
30.6 CNY
Undervaluation 34%
Intrinsic Value
Price
H

See Also

What is Huaxia Eye Hospital Group Co Ltd's Depreciation & Amortization?
Depreciation & Amortization
-90m CNY

Based on the financial report for Dec 31, 2023, Huaxia Eye Hospital Group Co Ltd's Depreciation & Amortization amounts to -90m CNY.

What is Huaxia Eye Hospital Group Co Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
-22%

Over the last year, the Depreciation & Amortization growth was -13%. The average annual Depreciation & Amortization growth rates for Huaxia Eye Hospital Group Co Ltd have been -22% over the past three years .

Back to Top